Cargando…

The Enhanced Pharmacological Effects of Modified Traditional Chinese Medicine in Attenuation of Atherosclerosis Is Driven by Modulation of Gut Microbiota

Accumulating evidence indicated that gut microbiota-targeted therapy is a promising strategy to treat Cardiovascular Disease (CVD). Traditional Chinese Medicine (TCM) has been used in CVD treatments for over 2,000 years which is believed to result from the modulation of gut microbiota, yet the under...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Wenyan, Jiang, Ting, Sun, Zheng, Teng, Fei, Ma, Chenchen, Huang, Shi, Yan, Suhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7593568/ https://www.ncbi.nlm.nih.gov/pubmed/33178012 http://dx.doi.org/10.3389/fphar.2020.546589

Ejemplares similares

Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
por: Yang, Shengjie, et al.
Publicado: (2021)

Gut microbiota, a hidden protagonist of traditional Chinese medicine for acute ischemic stroke
por: Gao, Lin, et al.
Publicado: (2023)

The Role of Gut Microbiota in Atherosclerosis and Hypertension
por: Ma, Junli, et al.
Publicado: (2018)

Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment
por: Zhang, Runzhi, et al.
Publicado: (2019)

Gut fungi differentially response to the antipyretic (heat-clearing) and diaphoretic (exterior-releasing) traditional Chinese medicines in Coptis chinensis-conditioned gut microbiota
por: Yang, Yanan, et al.
Publicado: (2022)

Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery
por: Zhang, Wenjuan, et al.
Publicado: (2019)

Phytochemistry, Pharmacology and Quality Control of Xiasangju: A Traditional Chinese Medicine Formula
por: Wu, Siyuan, et al.
Publicado: (2022)

Natural products of traditional Chinese medicine treat atherosclerosis by regulating inflammatory and oxidative stress pathways
por: Meng, Tianwei, et al.
Publicado: (2022)

Traditional Chinese Medicine and Gut Microbiome: Their Respective and Concert Effects on Healthcare
por: Zhang, Runzhi, et al.
Publicado: (2020)

Chinese Herbal Medicines Attenuate Acute Pancreatitis: Pharmacological Activities and Mechanisms
por: Xiang, Hong, et al.
Publicado: (2017)

Mitochondria as novel mediators linking gut microbiota to atherosclerosis that is ameliorated by herbal medicine: A review
por: Li, Yujuan, et al.
Publicado: (2023)

Assesment of Adulterated Traditional Chinese Medicines in China: 2003-2017
por: Xu, Mingzhe, et al.
Publicado: (2019)

Traditional Chinese Medicine of Angelicae Pubescentis Radix: A Review of Phytochemistry, Pharmacology and Pharmacokinetics
por: Lu, Yaqi, et al.
Publicado: (2020)

Anti-atherosclerosis mechanisms associated with regulation of non-coding RNAs by active monomers of traditional Chinese medicine
por: Liu, Guoqing, et al.
Publicado: (2023)

Editorial: Network Pharmacology and Traditional Medicine
por: Lai, Xinxing, et al.
Publicado: (2020)

Application of network pharmacology in the study of the mechanism of action of traditional chinese medicine in the treatment of COVID-19
por: Zheng, Shihao, et al.
Publicado: (2022)

Ginsenoside Rc ameliorated atherosclerosis via regulating gut microbiota and fecal metabolites
por: Xie, Bin, et al.
Publicado: (2022)

Research Advances in Pharmacology, Safety, and Clinical Applications of Yunnan Baiyao, a Traditional Chinese Medicine Formula
por: Yao, Qi, et al.
Publicado: (2021)

Editorial: Assessing the Pharmacological Effects and Therapeutic Potential of Traditional Chinese Medicine in Neurological Disease Models: An Update
por: Deng, Zhiqiang, et al.
Publicado: (2022)

Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE(-/-) Mice
por: Zhu, Boran, et al.
Publicado: (2020)

Targeting gut microbiota and immune crosstalk: potential mechanisms of natural products in the treatment of atherosclerosis
por: Jing, Jinpeng, et al.
Publicado: (2023)

Network pharmacological analysis of Xuefu Zhuyu decoction in the treatment of atherosclerosis
por: Yuan, Jinxia, et al.
Publicado: (2022)

Xin Su Ning—A Review of Basic and Clinical Pharmacology Integrated With Traditional Chinese Medicine Antiarrhythmic Theory
por: Wang, Xuan, et al.
Publicado: (2021)

Mercury and Mercury-Containing Preparations: History of Use, Clinical Applications, Pharmacology, Toxicology, and Pharmacokinetics in Traditional Chinese Medicine
por: Zhao, Meiling, et al.
Publicado: (2022)

Multi-level advances in databases related to systems pharmacology in traditional Chinese medicine: a 60-year review
por: Fan, Mengyue, et al.
Publicado: (2023)

Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
por: Li, Jinfan, et al.
Publicado: (2023)

Macrophage Death as a Pharmacological Target in Atherosclerosis
por: Martinet, Wim, et al.
Publicado: (2019)

Traditional Chinese Medicine Intervenes in Vascular Dementia: Traditional Medicine Brings New Expectations
por: Bai, Xue, et al.
Publicado: (2021)

Systems Pharmacology–Based Dissection of Anti-Cancer Mechanism of Traditional Chinese Herb Saussurea involucrata
por: Zhang, Qian, et al.
Publicado: (2021)

Pharmacological targeting of gastric mucosal barrier with traditional Chinese medications for repairing gastric mucosal injury
por: Jia, Xueyan, et al.
Publicado: (2023)

Assessing the Pharmacological and Therapeutic Efficacy of Traditional Chinese Medicine Liangxue Tongyu Prescription for Intracerebral Hemorrhagic Stroke in Neurological Disease Models
por: Li, Xun, et al.
Publicado: (2018)

Red Yeast Rice: A Systematic Review of the Traditional Uses, Chemistry, Pharmacology, and Quality Control of an Important Chinese Folk Medicine
por: Zhu, Bo, et al.
Publicado: (2019)

Impact of Qi-Invigorating Traditional Chinese Medicines on Diffuse Large B Cell Lymphoma Based on Network Pharmacology and Experimental Validation
por: Huang, Qian, et al.
Publicado: (2021)

Regulatory effect of traditional Chinese medicine on gut microbiota in patients with atherosclerosis: A protocol for systematic review and meta-analysis
por: Huang, Langlang, et al.
Publicado: (2020)

Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
por: Wu, Min, et al.
Publicado: (2020)

Effect of Traditional Chinese Medicine on the Cardiovascular Diseases
por: Jiang, Yang, et al.
Publicado: (2022)

Traditional chinese medicine in coronary microvascular disease
por: Yang, Zhihua, et al.
Publicado: (2022)

Network Pharmacology and Data Mining Approach Reveal the Medication Rule of Traditional Chinese Medicine in the Treatment of Premenstrual Syndrome/Premenstrual Dysphoric Disorder
por: Qu, Songlin, et al.
Publicado: (2022)

An overview of traditional Chinese medicine affecting gut microbiota in obesity
por: Li, Donghui, et al.
Publicado: (2023)

Antidepressant Active Ingredients From Chinese Traditional Herb Panax Notoginseng: A Pharmacological Mechanism Review
por: Li, Yanwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q9ebedd990om8bacatvm0vigg1